About
Protein replacement therapies
Areas of Focus
Categories
Biologics & BiopharmaceuticalNJ, NY, PA
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
765
By Phase
PHASE2: 3PHASE1: 1PHASE1/PHASE2: 1
By Status
COMPLETED: 3ACTIVE_NOT_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06216366Lead Sponsor
Rhu-pGSN to Mitigate Proinflammatory Responses to Decompression in Healthy SCUBA Divers
PHASE2Active, not recruiting
36 participants
Started: Aug 15, 2025 · Completed: Dec 30, 2025
NCT05947955Lead Sponsor
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
PHASE2Recruiting
600 participants
Started: Oct 3, 2024 · Completed: Mar 1, 2027
NCT05789745Lead Sponsor
A Study to Evaluate Plasma Gelsolin in Healthy Volunteers
PHASE1Completed
32 participants
Started: Mar 14, 2023 · Completed: May 24, 2023
NCT04358406Lead Sponsor
Rhu-pGSN for Severe Covid-19 Pneumonia
PHASE2Completed
64 participants
Started: Jul 30, 2020 · Completed: Jan 28, 2022
NCT03466073Lead Sponsor
A Phase 1b/2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CAP
PHASE1/PHASE2Completed
33 participants
Started: Aug 28, 2018 · Completed: Apr 2, 2019
Locations (1)
Headquarters
North Brunswick, NJ, United States
Map
Loading map...